Photothermal-Responsive Phase Transition of Proteoliposomes for Heat Shock Protein Sequestering against Cancer Thermoresistance
Research · 01.01.2026 · 9
DOI: 10.34133/research.1231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research, online erschienen am 31.03.2026. Verfasst von Kai Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The Chinese University of Hong Kong, Hong Kong SAR, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Chinese University of Hong Kong, CUHK.
Abstract (Originalsprache)
Photothermal therapy (PTT) has garnered considerable attention for its noninvasive and localized treatment advantages. However, in response to PTT-induced hyperthermia, cancer cells increase the expression level of heat shock proteins (HSPs) and activate thermoresistance to shield themselves from heat-induced damage, thereby diminishing the efficacy of PTT. To overcome thermoresistance, here we have developed an on-demand responsive proteoliposome (PL) system. This system consists of PLs formed by a phospholipid conjugate of an elastin-like polypeptide (ELP) with vanadium oxide nanozymes (VO x NZs) incorporated in the lumen, referred to as VO x @ELP-PL. Upon photoirradiation, the enclosed VO x NZs generate a photothermal effect, inducing hyperthermia and enhancing HSP expression in cancer cells. Concurrently, as the temperature surpasses a critical threshold, ELP-PL undergoes liquid–liquid phase separation (LLPS) in situ, transitioning from a liposome state to ELP coacervate droplets. In the hyperthermic cancer cells, ELP coacervate droplets sequester and insulate the up-regulated HSPs, disrupting the thermoprotective response of thermoresistant cancer cells. Moreover, VO x @ELP-PL combines peroxidase-catalyzed generation of toxic hydroxyl radicals with coacervate droplet-mediated sequestration of HSPs, leading to potentiated immunogenic cell death both in vitro and in vivo. In a mouse model of colon cancer, intravenously injected VO x @ELP-PL showed marked tumor enrichment and resulted in highly effective cancer treatment. Altogether, this system presents a novel strategy to counteract thermoresistance by sequestering HSPs via LLPS of ELP-PL, thereby augmenting the effectiveness of PTT in cancer therapy.
Autor:innen und Institutionen
- Department of Chemistry, The Chinese University of Hong Kong, Hong Kong SAR, China.
- MOE Key Laboratory for Biomedical Photonics - Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Tec…
- AoE Centre for Plant Vacuole Biology and Biotechnology, The Chinese University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Yuan-Di Zhao, Jiang Xia
Förderung
- National Natural Science Foundation of China
- Chinese University of Hong Kong
- CUHK
- Technology Innovation Program of Hubei Province
- 1+1+1 CUHK-CUHK(SZ)-GDST Joint Collaboration Fund
Zitieren
APA
Cheng, K., Han, Y., Zhang, F., Li, B., Zeng, B., Zhao, Y. D., & Xia, J. (2026). Photothermal-Responsive Phase Transition of Proteoliposomes for Heat Shock Protein Sequestering against Cancer Thermoresistance. Research, 9. https://doi.org/10.34133/research.1231
Vancouver
Cheng K, Han Y, Zhang F, Li B, Zeng B, Zhao YD, et al. Photothermal-Responsive Phase Transition of Proteoliposomes for Heat Shock Protein Sequestering against Cancer Thermoresistance. Research. 2026;9. doi:10.34133/research.1231
BibTeX
@article{Cheng2026,
author = {Cheng, Kai and Han, Yongxu and Zhang, Fang and Li, Biquan and Zeng, Bin and Zhao, Yuan-Di and Xia, Jiang},
title = {Photothermal-Responsive Phase Transition of Proteoliposomes for Heat Shock Protein Sequestering against Cancer Thermoresistance},
journal = {Research},
year = {2026},
volume = {9},
doi = {10.34133/research.1231}
}
EUVIMED